FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387207598> ?p ?o ?g. }

• W4387207598 endingPage "e360" @default.
• W4387207598 startingPage "e359" @default.
• W4387207598 abstract "The purpose was to compare the treatment outcomes of radical chemoradiotherapy versus radical surgery plus adjuvant chemotherapy or chemoradiotherapy in locally advanced primary small cell carcinoma of the esophagus (LA-PSCCE). The hypothesis was that radical chemoradiotherapy had better overall survival (OS) than radical surgery plus adjuvant chemotherapy or chemoradiotherapy.This large-scale multicenter retrospective study in China enrolled patients with newly diagnosed LA-PSCCE (T3-4N0M0 or TanyN+M0, AJCC 8th edition) from 2008 to 2021. According to different curative treatment approaches, patients were divided into two groups: radical chemoradiotherapy (group: CRT), and radical surgery following adjuvant chemotherapy or chemoradiotherapy (group: S + CT/CRT). The propensity score match (PSM) was applied to reduce the effect of confounding biases in clinicopathological characteristics (age, gender, KPS, tumor location, tumor length, and cTNM stage). Univariate Cox-regression analysis and Kaplan-Meier curve were calculated for OS. Statistical results were summarized as hazard ratio (HR), 95% confidence interval (CI) and P value. A two-sided P < 0.05 was regarded to be statistically significant.A total of 291 patients with a median follow-up of 4.3 years were retrospectively enrolled. After PSM analysis, 94 and 94 patients were eventually included in group CRT and S + CT/CRT, respectively. Group CRT demonstrated a significantly superior survival than group S + CT/CRT (HR, 0.63; 95% CI, 0.43-0.91; P = 0.01), with a 3-year OS of 49.5% and 27.8% (P = 0.02), respectively. In secondary analysis, patients treated with radical chemoradiotherapy consistently showed significant survival benefit than those with radical surgery plus adjuvant chemoradiotherapy (HR, 0.4; 95% CI, 0.21-0.79; P = 0.008).For patients with newly diagnosed LA-PSCCE, radical chemoradiotherapy should be a preferred recommendation in real-world clinical practice." @default.
• W4387207598 created "2023-09-30" @default.
• W4387207598 creator A5013134577 @default.
• W4387207598 creator A5029470409 @default.
• W4387207598 creator A5030040961 @default.
• W4387207598 creator A5046789366 @default.
• W4387207598 creator A5068428294 @default.
• W4387207598 creator A5071255673 @default.
• W4387207598 date "2023-10-01" @default.
• W4387207598 modified "2023-10-17" @default.
• W4387207598 title "Radical Chemoradiotherapy vs. Radical Surgery plus Adjuvant Chemotherapy or Chemoradiotherapy in Locally Advanced Primary Small Cell Carcinoma of the Esophagus: A Multicenter Retrospective Study in China" @default.
• W4387207598 doi "https://doi.org/10.1016/j.ijrobp.2023.06.2446" @default.
• W4387207598 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37785236" @default.
• W4387207598 hasPublicationYear "2023" @default.
• W4387207598 type Work @default.
• W4387207598 citedByCount "0" @default.
• W4387207598 crossrefType "journal-article" @default.
• W4387207598 hasAuthorship W4387207598A5013134577 @default.
• W4387207598 hasAuthorship W4387207598A5029470409 @default.
• W4387207598 hasAuthorship W4387207598A5030040961 @default.
• W4387207598 hasAuthorship W4387207598A5046789366 @default.
• W4387207598 hasAuthorship W4387207598A5068428294 @default.
• W4387207598 hasAuthorship W4387207598A5071255673 @default.
• W4387207598 hasConcept C121608353 @default.
• W4387207598 hasConcept C126322002 @default.
• W4387207598 hasConcept C141071460 @default.
• W4387207598 hasConcept C143998085 @default.
• W4387207598 hasConcept C144301174 @default.
• W4387207598 hasConcept C167135981 @default.
• W4387207598 hasConcept C207103383 @default.
• W4387207598 hasConcept C2776694085 @default.
• W4387207598 hasConcept C2776874909 @default.
• W4387207598 hasConcept C2778424827 @default.
• W4387207598 hasConcept C38180746 @default.
• W4387207598 hasConcept C44249647 @default.
• W4387207598 hasConcept C71924100 @default.
• W4387207598 hasConceptScore W4387207598C121608353 @default.
• W4387207598 hasConceptScore W4387207598C126322002 @default.
• W4387207598 hasConceptScore W4387207598C141071460 @default.
• W4387207598 hasConceptScore W4387207598C143998085 @default.
• W4387207598 hasConceptScore W4387207598C144301174 @default.
• W4387207598 hasConceptScore W4387207598C167135981 @default.
• W4387207598 hasConceptScore W4387207598C207103383 @default.
• W4387207598 hasConceptScore W4387207598C2776694085 @default.
• W4387207598 hasConceptScore W4387207598C2776874909 @default.
• W4387207598 hasConceptScore W4387207598C2778424827 @default.
• W4387207598 hasConceptScore W4387207598C38180746 @default.
• W4387207598 hasConceptScore W4387207598C44249647 @default.
• W4387207598 hasConceptScore W4387207598C71924100 @default.
• W4387207598 hasIssue "2" @default.
• W4387207598 hasLocation W43872075981 @default.
• W4387207598 hasLocation W43872075982 @default.
• W4387207598 hasOpenAccess W4387207598 @default.
• W4387207598 hasPrimaryLocation W43872075981 @default.
• W4387207598 hasRelatedWork W1900595920 @default.
• W4387207598 hasRelatedWork W2042811308 @default.
• W4387207598 hasRelatedWork W2100497053 @default.
• W4387207598 hasRelatedWork W2114624491 @default.
• W4387207598 hasRelatedWork W2166867133 @default.
• W4387207598 hasRelatedWork W2194631636 @default.
• W4387207598 hasRelatedWork W2790169890 @default.
• W4387207598 hasRelatedWork W2889691785 @default.
• W4387207598 hasRelatedWork W2972384828 @default.
• W4387207598 hasRelatedWork W4384497977 @default.
• W4387207598 hasVolume "117" @default.
• W4387207598 isParatext "false" @default.
• W4387207598 isRetracted "false" @default.
• W4387207598 workType "article" @default.